Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Interactive Brokers
IBKR
$41.4B
| $4.63M | 0.01% |
544,120
+345,032
| +173% | +$2.74M |
|
1602
iShares MSCI Mexico ETF
EWW
$1.91B
| $4.62M | 0.01% |
81,103
-81,743
| -50% | -$4.77M |
|
1603
CALL
Norfolk Southern
NSC
$75.5B
| $4.62M | 0.01% |
45,300
-98,300
| -68% | -$10.5M |
|
1604
CALL
Ionis Pharmaceuticals
IONS
$9.5B
| $4.62M | 0.01% |
73,300
-30,700
| -30% | -$2.08M |
|
|
ATHN
1605
CALL
DELISTED
Athenahealth, Inc.
ATHN
| $4.62M | 0.01% |
38,800
+16,900
| +77% | +$2.25M |
|
1606
PUT
ProShares UltraPro S&P 500
UPRO
$5.75B
| $4.62M | 0.01% |
416,400
+97,200
| +30% | +$1.08M |
|
|
WLL
1607
CALL
DELISTED
Whiting Petroleum Corporation
WLL
| $4.61M | 0.01% |
513
+73
| +17% | +$739K |
|
1608
PUT
Tenet Healthcare
THC
$21B
| $4.59M | 0.01% |
93,700
-26,900
| -22% | -$1.26M |
|
|
DO
1609
CALL
DELISTED
Diamond Offshore Drilling
DO
| $4.58M | 0.01% |
176,000
-120,000
| -41% | -$3.74M |
|
1610
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $4.57M | 0.01% |
60,900
+34,500
| +131% | +$2.41M |
|
|
GPOR
1611
DELISTED
Gulfport Energy Corp.
GPOR
| $4.57M | 0.01% |
101,508
+25,335
| +33% | +$1.07M |
|
1612
CALL
American Tower
AMT
$78.8B
| $4.54M | 0.01% |
48,300
-69,300
| -59% | -$6.74M |
|
1613
CALL
Abercrombie & Fitch
ANF
$5.27B
| $4.53M | 0.01% |
206,000
+102,400
| +99% | +$2.52M |
|
1614
EPR Properties
EPR
$4.63B
| $4.52M | 0.01% |
75,377
+1,875
| +3% | +$115K |
|
|
WLL
1615
DELISTED
Whiting Petroleum Corporation
WLL
| $4.52M | 0.01% |
503
+79
| +19% | +$800K |
|
|
VSI
1616
CALL
DELISTED
Vitamin Shoppe Inc.
VSI
| $4.51M | 0.01% |
110,100
+105,200
| +2,147% | +$4.45M |
|
1617
AB InBev
BUD
$163B
| $4.51M | 0.01% |
37,303
-11,016
| -23% | -$1.33M |
|
|
DNKN
1618
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $4.5M | 0.01% |
95,851
-74,168
| -44% | -$3.44M |
|
|
TYC
1619
CALL
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $4.5M | 0.01% |
99,988
+77,450
| +344% | +$3.45M |
|
|
NBIS
1620
Nebius Group N.V.
NBIS
$47.1B
| $4.5M | 0.01% |
300,050
-21,506
| -7% | -$346K |
|
1621
PUT
Precigen
PGEN
$2.52B
| $4.5M | 0.01% |
+104,633
| New | +$3.76M |
|
|
NTI
1622
DELISTED
NORTHERN TIER ENERGY LP CLASS A
NTI
| $4.5M | 0.01% |
179,917
-22,323
| -11% | -$514K |
|
|
SPLK
1623
PUT
DELISTED
Splunk Inc
SPLK
| $4.5M | 0.01% |
76,200
-72,500
| -49% | -$4.38M |
|
1624
W.P. Carey
WPC
$16B
| $4.49M | 0.01% |
67,419
+1,100
| +2% | +$75.6K |
|
1625
CALL
Lam Research
LRCX
$385B
| $4.49M | 0.01% |
641,000
-78,000
| -11% | -$617K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.